Search

Search Results
Results 311 - 320 of 511 for breast cancer
  • Noxafil concentrated injection
    Drug - 25 Nov 2021
    Consumer Medicine Information (CMI) about Noxafil concentrated injection intended for persons living in Australia.
  • Noxafil
    Drug - 25 Nov 2021
    Consumer Medicine Information (CMI) about Noxafil intended for persons living in Australia.
  • Vectibix
    Drug - 9 Sep 2021
    Consumer Medicine Information (CMI) about Vectibix intended for persons living in Australia.
  • Risperdal Tablets and Solution
    Drug - 27 Aug 2021
    Consumer Medicine Information (CMI) about Risperdal Tablets and Solution (Risperidone) intended for persons living in Australia.
  • Actiq
    Drug - 12 Aug 2021
    Consumer Medicine Information (CMI) about Actiq (fentanyl citrate) intended for persons living in Australia.
  • Thyrogen
    Drug - 14 Apr 2021
    Consumer Medicine Information (CMI) about Thyrogen intended for persons living in Australia.
  • Valcyte Powder for Oral Solution
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Valcyte Powder for Oral Solution (valganciclovir) intended for persons living in Australia.
  • Fluanxol
    Drug - 7 Oct 2020
    Consumer Medicine Information (CMI) about Fluanxol (Flupentixol decanoate) intended for persons living in Australia.
  • Risperdal Consta
    Drug - 11 Aug 2020
    Consumer Medicine Information (CMI) about Risperdal Consta (Risperidone) intended for persons living in Australia.
  • Jadenu
    Drug - 5 Dec 2019
    Consumer Medicine Information (CMI) about Jadenu (deferasirox) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback